- Home
- MUX vs ZBIO Comparison
MUX vs ZBIO Comparison
Compare MUX & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUX
- ZBIO
- Stock Information
- Founded
- MUX 1979
- ZBIO 2019
- Country
- MUX Canada
- ZBIO United States
- Employees
- MUX N/A
- ZBIO N/A
- Industry
- MUX Precious Metals
- ZBIO
- Sector
- MUX Basic Materials
- ZBIO
- Exchange
- MUX Nasdaq
- ZBIO NYSE
- Market Cap
- MUX 423.9M
- ZBIO 389.2M
- IPO Year
- MUX N/A
- ZBIO 2024
- Fundamental
- Price
- MUX $7.66
- ZBIO $10.02
- Analyst Decision
- MUX Strong Buy
- ZBIO Strong Buy
- Analyst Count
- MUX 2
- ZBIO 7
- Target Price
- MUX $15.25
- ZBIO $32.29
- AVG Volume (30 Days)
- MUX 746.3K
- ZBIO 215.4K
- Earning Date
- MUX 05-07-2025
- ZBIO 05-16-2025
- Dividend Yield
- MUX N/A
- ZBIO N/A
- EPS Growth
- MUX N/A
- ZBIO N/A
- EPS
- MUX N/A
- ZBIO N/A
- Revenue
- MUX $174,477,000.00
- ZBIO $5,000,000.00
- Revenue This Year
- MUX $29.49
- ZBIO N/A
- Revenue Next Year
- MUX N/A
- ZBIO N/A
- P/E Ratio
- MUX N/A
- ZBIO N/A
- Revenue Growth
- MUX 4.96
- ZBIO N/A
- 52 Week Low
- MUX $6.38
- ZBIO $5.83
- 52 Week High
- MUX $12.50
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- MUX 49.49
- ZBIO N/A
- Support Level
- MUX $7.42
- ZBIO N/A
- Resistance Level
- MUX $8.42
- ZBIO N/A
- Average True Range (ATR)
- MUX 0.42
- ZBIO 0.00
- MACD
- MUX 0.00
- ZBIO 0.00
- Stochastic Oscillator
- MUX 56.92
- ZBIO 0.00
About MUX McEwen Mining Inc.
McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company primarily generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, most production occurs in the United States.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.